NCT04224038 The Inspire Bio-resource Research Platform for Healthy Aging INSPIRE Platform
| NCT ID | NCT04224038 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Toulouse |
| Condition | Biological Aging |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2019-10-16 |
| Primary Completion | 2031-10-16 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2019-10-16 with a primary completion date of 2031-10-16.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Since aging is a systemic (not organ-specific) phenomenon, the main objective of Inspire Bio-resource Research Platform for Healthy Aging is to build a comprehensive research platform gathering biological, clinical (including imaging) and digital resources that will be explored to identify robust (set of) markers of aging, age-related diseases and IC evolution. The Inspire Platform will gather data and biospecimens from subjects of different ages (from 30 years or over - no upper limit for age) and functional capacity levels (from robust to frail to disabled) over 10 years.
Eligibility Criteria
Inclusion Criteria: * Aged 30 years-old or over; * Both sexes * Affiliated to a social security scheme Exclusion Criteria: * severe disease compromising life expectancy at 5 years; * Deprived of their liberty by administrative or judicial decision, or under guardianship
Contact & Investigator
Bruno VELLAS, MD
PRINCIPAL INVESTIGATOR
University Hospital of Toulouse
Frequently Asked Questions
Who can join the NCT04224038 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, studying Biological Aging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04224038 currently recruiting?
Yes, NCT04224038 is actively recruiting participants. Contact the research team at vellas.b@chu-toulouse.fr for enrollment information.
Where is the NCT04224038 trial being conducted?
This trial is being conducted at Toulouse, France.
Who is sponsoring the NCT04224038 clinical trial?
NCT04224038 is sponsored by University Hospital, Toulouse. The principal investigator is Bruno VELLAS, MD at University Hospital of Toulouse. The trial plans to enroll 1,000 participants.